Clincosm LogoSign in Get a demo

Metabolic Profile and Adipokine Levels in Young Hyperandrogenemic Females

Sponsor
Medical University of Gdansk (Other)
Overall Status
Recruiting
CT.gov ID
NCT05112029
Collaborator
(none)
40
Enrollment
1
Location
8.3
Anticipated Duration (Months)
4.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Assessement of basic metabolic profile and adipokine levels in young hyperandrogenemic females.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    40 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Metabolic Profile and Adipokine Levels in Young Hyperandrogenemic Females
    Actual Study Start Date :
    Sep 22, 2021
    Anticipated Primary Completion Date :
    Jun 1, 2022
    Anticipated Study Completion Date :
    Jun 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Basic metabolic profile. [Day of blood testing - no further assessment planned (observational study).]

      Serum lipids, uric acid, fasting glucose and insulin.

    2. Adipokines. [Day of blood testing - no further assessment planned (observational study).]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 40 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • hyperandrogenemia

    • informed consent to participate

    • female sex

    • age 18-40 years old

    Exclusion Criteria:

    • male sex

    • no consent given

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Endocrinology and Internal Medicine, Medical University of Gdansk Gdańsk Poland

    Sponsors and Collaborators

    • Medical University of Gdansk

    Investigators

    • Study Director: Renata Świątkowska-Stodulska, MD PhD, Medical University of Gdansk
    • Principal Investigator: Agata Berlińska, MD, Medical University of Gdansk

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Medical University of Gdansk
    ClinicalTrials.gov Identifier:
    NCT05112029
    Other Study ID Numbers:
    • ADIP-AN
    First Posted:
    Nov 8, 2021
    Last Update Posted:
    Nov 8, 2021
    Last Verified:
    Oct 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Hyperandrogenism
    Metabolic Syndrome
    Metabolic Diseases

    Study Results

    No Results Posted as of Nov 8, 2021